🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a two-center open-label non-randomized proof of principle study con...
Status
Active Not Recruiting
Location
Netherlands Cancer Institute
Start Date
2023-07-28
Trial ID
NCT05700656
Treatments Being Tested
The study involves a single dose of galunisertib taken by mouth by Japanese...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Start Date
2016-04
Trial ID
NCT02752919
Treatments Being Tested
Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive neurodege...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-30
Trial ID
NCT07321860
Treatments Being Tested
The main purpose of this study is to evaluate safety and tolerability of LY...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2014-11-12
Trial ID
NCT02240433
The primary objective of this study is to compare the progression free surv...
Status
Active Not Recruiting
Location
Sibley Memorial Hospital
Start Date
2016-05-03
Trial ID
NCT02452008
Treatments Being Tested
Patients with metastatic breast cancer receiving at least one single agent ...
Status
Terminated
Location
Weill Cornell Medical College
Start Date
2015-08-10
Trial ID
NCT02538471
Treatments Being Tested
This study involves a single dose of 150 milligram (mg) of radiolabeled LY2...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2013-01
Trial ID
NCT01746004
Treatments Being Tested
This phase I trial studies the side effects and best dose of Galunisertib w...
Status
Completed
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2016-03
Trial ID
NCT02672475
Treatments Being Tested
The main purpose of this study is to evaluate the safety and side effects o...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559 ) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2012-11
Trial ID
NCT01722825
Treatments Being Tested
To determine the safety and tolerability of galunisertib when combined with...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2017-03-30
Trial ID
NCT02906397
Treatments Being Tested